ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
•13 Apr 2020 09:17

Celltrion Healthcare Macro Bull Energy to Test 2018 Highs

Celltrion Healthcare (091990 KS) shows clear risk support to work with for a stop, setting the stage to buy weakness with the summer 2018 highs...

Share
•08 Apr 2020 07:10

Big Short Covering on Celltrion Inc & Celltrion Healthcare

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 3 April 2020, the...

Logo
561 Views
Share
•07 Apr 2020 03:45

Celltrion Healthcare Block Deals: Conditions, Discount, Overhang, & Arb Yield

It is now clear that neither OEP or Ion (Temasek) wants to stay at Celltrion as a long-term investor. Celltrion management reportedly asked OEP...

Logo
493 Views
Share
•06 Apr 2020 19:19

Another Block Deal for Celltrion Healthcare

After the market close today, Celltrion Healthcare (091990 KS) announced that there will be a block deal worth about 272 billion won ($221 million)...

Logo
482 Views
Share
•06 Apr 2020 17:39

Celltrion Healthcare Placement - One Equity Partners Back on the Market Again After Temasek

One Equity Partners is looking to sell 3.5m shares in Celltrion Healthcare (091990 KS). Post-placement, One Equity Partners will still have about a...

Share
x